Alcon, Inc. Subsidiary Announces Closing on Sale of Madrid, Spain Manufacturing Facility
November 06 2003 - 8:01AM
PR Newswire (US)
Alcon, Inc. Subsidiary Announces Closing on Sale of Madrid, Spain
Manufacturing Facility HUNENBERG, Switzerland, Nov. 6
/PRNewswire-FirstCall/ -- Alcon, Inc.'s wholly owned subsidiary,
Alcon CUSI, S.A., today completed the sale of its contact lens care
solutions manufacturing facility located in Madrid, Spain to AMO
Manufacturing Spain, S.L., a wholly owned subsidiary of Advanced
Medical Optics, Inc. for approximately $22 million. Alcon will
realize a pre-tax gain of approximately $8 million from the sale,
which has been incorporated into the company's prior earnings
guidance for the fourth quarter of 2003. AMO has committed to
employ the facility's entire related work force. The production of
contact lens care products previously manufactured in Madrid has
been transferred to the Alcon plant in Fort Worth, Texas. "The sale
of this plant optimizes capacity levels, streamlines manufacturing
and distribution operations, gains efficiencies and reduces total
production costs for contact lens care solutions," said Andre Bens,
Ph.D., Alcon senior vice president, Global Manufacturing and
Technical Support. Alcon is the world's leading eye care company
and has been dedicated to the ophthalmic industry for more than 50
years. Alcon develops, manufactures and markets pharmaceuticals,
surgical equipment and devices, contact lens solutions and other
vision care products that treat diseases, disorders and other
conditions of the eye. Caution Concerning Forward-Looking
Statements. This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995, relating principally to the completion of the sale of the
Madrid plant. These statements involve known and unknown risks,
uncertainties and other factors which may cause our actual results,
performance or achievements to be materially different from any
future results, performances or achievements expressed or implied
by our forward-looking statements. These statements reflect the
views of our management as of the date of this press release with
respect to future events and are based on assumptions and subject
to risks and uncertainties. Given these uncertainties, you should
not place undue reliance on these forward- looking statements. You
should read this press release with the understanding that our
actual future results may be materially different from what we
expect. Except to the extent required under the federal securities
laws and the rules and regulations promulgated by the Securities
and Exchange Commission, we undertake no obligation to publicly
update or revise any of these forward-looking statements, whether
to reflect new information or future events or circumstances or
otherwise. For information, contact: Doug MacHatton (Investor
Relations) 800-400-8599 News media and other inquiries: Mary Dulle
(Public Relations) 817-551-8058 http://www.alconinc.com/
DATASOURCE: Alcon, Inc. CONTACT: Doug MacHatton, Investor
Relations, +1-800-400-8599, or news media and other inquiries, Mary
Dulle, Public Relations, +1-817-551-8058, both of Alcon, Inc. Web
site: http://www.alconinc.com/
Copyright
Advanced medical Optics (NYSE:AVO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Advanced medical Optics (NYSE:AVO)
Historical Stock Chart
From Jul 2023 to Jul 2024